Phase II Trail of REVLIMID (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas

  • Ain, Kenneth (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date2/2/066/24/20